Skip to content

Study · Animal study (in vivo) · rat · 1988

6 results

The circadian cycle effects of DSIP on colonic temperature, blood pressure, and heart rate in control and area postrema-lesioned rats.

Yehuda S, Caspy T, Carasso RL

The International journal of neuroscience1 Oct 1988Cited by 7 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study6

6 results from studies that gave the peptide. No result from this study comes from people.

  1. 01AnimalAnimal study (in vivo)Efficacy outcome

    In control rats, DSIP induced a shift in the hyperthermic cycle of colonic temperature.

    In plain wordsIn rats, DSIP shifted the daily cycle of raised body temperature.

    Outcome
    MixedCircadian colonic temperature cycle in control rats
    Study

    ratn: not reported in source

    Comparator
    Saline
    Outcome group
    Body temperature · Whole body
    Studied dose
    0.1 mg/kg · intraperitonealAs given in this study (rat).

    Source sentences

    Summary
    DSIP induced a shift in the hyperthermic cycle of control rats
    1 context sentence
    Summary · context
    Groups of control and Area Postrema rats were treated with 0.1 mg/kg, i.p., DSIP or with saline, at 06:00, 09:00, 12:00, 15:00, 18:00, 21:00, 24:00, and at 03:00. Colonic temperature, blood pressure, and heart rate were measured 30 min after treatment.
  2. 02AnimalAnimal study (in vivo)Efficacy outcome

    In area postrema-lesioned rats, DSIP did not modify the noncyclic hypothermia.

    In plain wordsIn rats with a lesion in the area postrema, DSIP did not change their low body temperature.

    Outcome
    No significant changeColonic temperature in area postrema-lesioned rats
    Study

    ratn: not reported in source

    Comparator
    Saline
    Outcome group
    Body temperature · Whole body
    Studied dose
    0.1 mg/kg · intraperitonealAs given in this study (rat).

    Source sentences

    Summary
    but was unable to modify the noncyclic hypothermia found among Area Postrema-lesioned rats.
    1 context sentence
    Summary · context
    Groups of control and Area Postrema rats were treated with 0.1 mg/kg, i.p., DSIP or with saline, at 06:00, 09:00, 12:00, 15:00, 18:00, 21:00, 24:00, and at 03:00. Colonic temperature, blood pressure, and heart rate were measured 30 min after treatment.
  3. 03AnimalAnimal study (in vivo)Efficacy outcome

    In control rats, DSIP decreased blood pressure.

    In plain wordsIn rats, DSIP lowered blood pressure.

    Outcome
    DecreaseBlood pressure in control rats
    Study

    ratn: not reported in source

    Comparator
    Saline
    Outcome group
    Blood pressure · Cardiovascular
    Studied dose
    0.1 mg/kg · intraperitonealAs given in this study (rat).

    Source sentences

    Summary
    Furthermore, DSIP caused a decrease in the blood pressure level of control rats
    1 context sentence
    Summary · context
    Groups of control and Area Postrema rats were treated with 0.1 mg/kg, i.p., DSIP or with saline, at 06:00, 09:00, 12:00, 15:00, 18:00, 21:00, 24:00, and at 03:00. Colonic temperature, blood pressure, and heart rate were measured 30 min after treatment.
  4. 04AnimalAnimal study (in vivo)Efficacy outcome

    In area postrema-lesioned rats, DSIP had no effect on the already depressed blood pressure.

    In plain wordsIn rats with a lesion in the area postrema, DSIP did not change their already low blood pressure.

    Outcome
    No significant changeBlood pressure in area postrema-lesioned rats
    Study

    ratn: not reported in source

    Comparator
    Saline
    Outcome group
    Blood pressure · Cardiovascular
    Studied dose
    0.1 mg/kg · intraperitonealAs given in this study (rat).

    Source sentences

    Summary
    but had no such effect on the already depressed level of blood pressure in the Area Postrema-lesioned rats.
    1 context sentence
    Summary · context
    Groups of control and Area Postrema rats were treated with 0.1 mg/kg, i.p., DSIP or with saline, at 06:00, 09:00, 12:00, 15:00, 18:00, 21:00, 24:00, and at 03:00. Colonic temperature, blood pressure, and heart rate were measured 30 min after treatment.
  5. 05AnimalAnimal study (in vivo)Efficacy outcome

    In control rats, DSIP decreased heart rate.

    In plain wordsIn rats, DSIP slowed the heart rate.

    Outcome
    DecreaseHeart rate in control rats
    Study

    ratn: not reported in source

    Comparator
    Saline
    Outcome group
    Heart function · Cardiovascular
    Studied dose
    0.1 mg/kg · intraperitonealAs given in this study (rat).

    Source sentences

    Summary
    Finally, DSIP decreased the heart rate of control rats
    1 context sentence
    Summary · context
    Groups of control and Area Postrema rats were treated with 0.1 mg/kg, i.p., DSIP or with saline, at 06:00, 09:00, 12:00, 15:00, 18:00, 21:00, 24:00, and at 03:00. Colonic temperature, blood pressure, and heart rate were measured 30 min after treatment.
  6. 06AnimalAnimal study (in vivo)Efficacy outcome

    In area postrema-lesioned rats, DSIP significantly antagonized the elevated heart rate.

    In plain wordsIn rats with a lesion in the area postrema, DSIP lowered their raised heart rate.

    Outcome
    DecreaseElevated heart rate in area postrema-lesioned rats
    Study

    ratn: not reported in source

    Comparator
    Saline
    Outcome group
    Heart function · Cardiovascular
    Studied dose
    0.1 mg/kg · intraperitonealAs given in this study (rat).

    Source sentences

    Summary
    and significantly antagonized the elevated heart rate observed in the Area Postrema-lesioned rats.
    1 context sentence
    Summary · context
    Groups of control and Area Postrema rats were treated with 0.1 mg/kg, i.p., DSIP or with saline, at 06:00, 09:00, 12:00, 15:00, 18:00, 21:00, 24:00, and at 03:00. Colonic temperature, blood pressure, and heart rate were measured 30 min after treatment.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    10 Oct 2026, 09:43 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 03:04 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.